The findings presented here are consistent with the outcomes of the MDR reversal assay, which demonstrate that imperatorin has the ability to reinstate the sensitivity of cancer cells that overexpress ABCG2 by enhancing the intracellular accumulation of ABCG2 substrate drugs. This evidence concerns the gene ABCG2 and cancer.